Virtus NFJ Small-Cap Value Fund Class A
PCVAX
NASDAQ
| Weiss Ratings | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Virtus | |||
| Manager/Tenure (Years) | Paul A. Magnuson (30), John R. Mowrey (13), J. Garth Reilly (6), 1 other | |||
| Website | http://www.virtus.com | |||
| Fund Information | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Virtus NFJ Small-Cap Value Fund Class A | |||
| Category | Small Value | |||
| Sub-Category | US Equity Small Cap | |||
| Prospectus Objective | Small Company | |||
| Inception Date | Jan 20, 1997 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.71% | |||
| Dividend | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.93% | |||
| Asset Allocation | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.38% | |||
| Stock | 99.62% | |||
| U.S. Stock | 98.61% | |||
| Non-U.S. Stock | 1.01% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.67% | |||
| 30-Day Total Return | 0.30% | |||
| 60-Day Total Return | -2.62% | |||
| 90-Day Total Return | -3.25% | |||
| Year to Date Total Return | 15.07% | |||
| 1-Year Total Return | 21.58% | |||
| 2-Year Total Return | 15.73% | |||
| 3-Year Total Return | 42.64% | |||
| 5-Year Total Return | 27.21% | |||
| Price | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $13.36 | |||
| 1-Month Low NAV | $13.05 | |||
| 1-Month High NAV | $13.44 | |||
| 52-Week Low NAV | $11.21 | |||
| 52-Week Low NAV (Date) | Nov 20, 2025 | |||
| 52-Week High NAV | $14.06 | |||
| 52-Week High Price (Date) | Aug 17, 2026 | |||
| Beta / Standard Deviation | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.23 | |||
| Standard Deviation | 17.86 | |||
| Balance Sheet | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 237.03M | |||
| Operating Ratios | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.17% | |||
| Turnover Ratio | 87.00% | |||
| Performance | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 24.26% | |||
| Last Bear Market Total Return | -11.60% | |||